@misc{indiciaed950c24613c0,
  title = {MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer},
  author = {Prasad, M. and Zorea, J. and Jagadeeshan, S. and Shnerb, A. and Bouaoud, J. and Michon, L. and Novoplansky, O. and Badarni, M. and Cohen, L. and Yagodayev, K. and Tzadok, S. and Rotblat, B. and Brezina, L. and Mock, A. and Karabajakian, A. and Fayette, J. and Cohen, I. and Cooks, T. and Allon, I. and Dimitstei, O. and Joshua, B. and Kong, D. and Voronov, E. and Scaltriti, M. and Carmi, Y. and Hess, J. and Morris, L. G. T. and Saintigny, P. and Elkabets, M.},
  year = {2021},
  doi = {10.1101/2021.08.22.457244},
  url = {https://www.biorxiv.org/content/10.1101/2021.08.22.457244v1},
  note = {Source identifier: 10.1101/2021.08.22.457244}
}